129 related articles for article (PubMed ID: 3606636)
1. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
Naguib FN; el Kouni MH; Chu SH; Cha S
Biochem Pharmacol; 1987 Jul; 36(13):2195-201. PubMed ID: 3606636
[TBL] [Abstract][Full Text] [Related]
2. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
el Kouni MH; el Kouni MM; Naguib FN
Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
[TBL] [Abstract][Full Text] [Related]
3. Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
el Kouni MH; Naguib FN; Chu SH; Cha SM; Ueda T; Gosselin G; Imbach JL; Shealy YF; Otter BA
Mol Pharmacol; 1988 Aug; 34(2):104-10. PubMed ID: 3412318
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines.
Park KS; el Kouni MH; Krenitsky TA; Chu SH; Cha S
Biochem Pharmacol; 1986 Nov; 35(21):3853-5. PubMed ID: 3535805
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.
Niedzwicki JG; el Kouni MH; Chu SH; Cha S
Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695
[TBL] [Abstract][Full Text] [Related]
6. Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii.
el Kouni MH; Naguib FN; Panzica RP; Otter BA; Chu SH; Gosselin G; Chu CK; Schinazi RF; Shealy YF; Goudgaon N; Ozerov AA; Ueda T; Iltzsch MH
Biochem Pharmacol; 1996 Jun; 51(12):1687-700. PubMed ID: 8687484
[TBL] [Abstract][Full Text] [Related]
7. 5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase.
el Kouni MH; Goudgaon NM; Rafeeq M; Al Safarjalani ON; Schinazi RF; Naguib FN
Biochem Pharmacol; 2000 Sep; 60(6):851-6. PubMed ID: 10930540
[TBL] [Abstract][Full Text] [Related]
8. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S
Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii.
Iltzsch MH; Klenk EE
Biochem Pharmacol; 1993 Nov; 46(10):1849-58. PubMed ID: 8250971
[TBL] [Abstract][Full Text] [Related]
10. Development of inhibitors of pyrimidine metabolism.
Cha SM
Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
Lee KH; el Kouni MH; Chu HS; Cha S
Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.
Orr GF; Musso DL; Boswell GE; Kelley JL; Joyner SS; Davis ST; Baccanari DP
J Med Chem; 1995 Sep; 38(19):3850-6. PubMed ID: 7562916
[TBL] [Abstract][Full Text] [Related]
13. 5-Substituted-2,2'-anhydrouridines, potent inhibitors of uridine phosphorylase.
Veres Z; Szabolcs A; Szinai I; Dénes G; Kajtár-Peredy M; Otvös L
Biochem Pharmacol; 1985 May; 34(10):1737-40. PubMed ID: 4004890
[TBL] [Abstract][Full Text] [Related]
14. 5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase.
Naguib FN; Levesque DL; Wang EC; Panzica RP; el Kouni MH
Biochem Pharmacol; 1993 Oct; 46(7):1273-83. PubMed ID: 8216379
[TBL] [Abstract][Full Text] [Related]
15. Uridine phosphorylase inhibitors: chemical modification of benzyloxybenzyl-barbituric acid and its effects on urdpase inhibition.
Guerin DJ; Mazeas D; Musale MS; Naguib FN; Al Safarjalani ON; el Kouni MH; Panzica RP
Bioorg Med Chem Lett; 1999 Jun; 9(11):1477-80. PubMed ID: 10386920
[TBL] [Abstract][Full Text] [Related]
16. Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase.
Goudgaon NM; Naguib FN; el Kouni MH; Schinazi RF
J Med Chem; 1993 Dec; 36(26):4250-4. PubMed ID: 8277507
[TBL] [Abstract][Full Text] [Related]
17. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
[TBL] [Abstract][Full Text] [Related]
18. Uridine phosphorylase from Hymenolepis diminuta (Cestoda): kinetics and inhibition by pyrimidine nucleoside analogs.
Drabikowska AK
Acta Biochim Pol; 1996; 43(4):733-41. PubMed ID: 9104511
[TBL] [Abstract][Full Text] [Related]
19. Uridine phosphorylase from Schistosoma mansoni.
el Kouni MH; Naguib FN; Niedzwicki JG; Iltzsch MH; Cha S
J Biol Chem; 1988 May; 263(13):6081-6. PubMed ID: 3360774
[TBL] [Abstract][Full Text] [Related]
20. Acyclonucleoside analogues consisting of 5- and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E. coli uridine phosphorylase.
Drabikowska AK; Lissowska L; Draminski M; Zgit-Wroblewska A; Shugar D
Z Naturforsch C J Biosci; 1987 Mar; 42(3):288-96. PubMed ID: 2954322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
